332.90 -15.60 (-4.48%)

New 52W Low today

333.8K NSE+BSE Volume

NSE 04 Apr, 2025 3:31 PM (IST)



Board Meetings - Aarti Drugs Ltd.

The latest board meeting for Aarti Drugs Ltd. took place on 29 Jan 2025, for the purpose of Quarterly Results & Interim Dividend

Ex-date Purpose Notes
29 Jan 2025 Quarterly Results & Interim Dividend -
24 Oct 2024 Quarterly Results -
26 Aug 2024 Buy Back of Shares -
26 Jul 2024 Quarterly Results -
03 May 2024 Audited Results -
24 Jan 2024 Quarterly Results & Interim Dividend -
19 Oct 2023 Quarterly Results -
21 Jul 2023 Quarterly Results & Buy Back -
29 Apr 2023 Audited Results -
27 Jan 2023 Quarterly Results & Interim Dividend -
20 Oct 2022 Quarterly Results -
27 Jul 2022 Quarterly Results -
09 May 2022 Audited Results -
31 Jan 2022 Audited Results & Interim Dividend -
27 Oct 2021 Quarterly Results -
27 Jul 2021 Quarterly Results -
15 May 2021 Audited Results -
19 Mar 2021 Buy Back of Shares -
25 Jan 2021 Quarterly Results -
23 Oct 2020 Audited Results -
20 Oct 2020 Audited Results & Interim Dividend -
20 Aug 2020 Bonus issue -
25 Jul 2020 Quarterly Results -
15 May 2020 Audited Results -
06 Feb 2020 Quarterly Results & Interim Dividend -
23 Oct 2019 Audited Results -
26 Jul 2019 Quarterly Results -
15 May 2019 Audited Results & Final Dividend -
15 Mar 2019 Buy Back of Shares -
11 Feb 2019 Quarterly Results -
02 Nov 2018 Quarterly Results -
13 Aug 2018 Quarterly Results -
16 May 2018 Audited Results & Final Dividend -
13 Feb 2018 Quarterly Results -
08 Jan 2018 Buy Back of Shares -
13 Nov 2017 Quarterly Results -
18 Aug 2017 Quarterly Results -
23 May 2017 Audited Results & Final Dividend -
08 Feb 2017 Quarterly Results -
09 Nov 2016 Quarterly Results -
17 Oct 2016 Buy Back of Shares -
12 Aug 2016 Quarterly Results -
05 May 2016 Audited Results -
16 Mar 2016 3rd Interim Dividend -
05 Feb 2016 Quarterly Results & 2nd Interim Dividend -
06 Nov 2015 Quarterly Results & Interim Dividend -
31 Jul 2015 Quarterly Results -
20 May 2015 Audited Results & Final Dividend -
26 Mar 2015 Others To consider & approve the allotment of 121,08,550 Equity shares as Bonus issue in the proportion of 1 new equity share for every 1 (One) existing fully paid equity shares.
30 Jan 2015 Quarterly Results & Interim Dividend Second Interim Dividend
14 Nov 2014 Quarterly Results & Interim Dividend -
08 Aug 2014 Quarterly Results -
30 Apr 2014 Audited Results & Final Dividend -
31 Jan 2014 Quarterly Results & 2nd Interim Dividend -
14 Nov 2013 Quarterly Results & Interim Dividend -
02 Aug 2013 Quarterly Results -
16 May 2013 Audited Results & Final Dividend -
06 Feb 2013 Quarterly Results & Interim Dividend -
31 Oct 2012 Quarterly Results & Interim Dividend -
10 Aug 2012 Quarterly Results -
09 Jul 2012 Audited Results Inter alia, to reconsider, approve and take on record the Audited Financial Results for the year ended March 31, 2012, post amalgamation of Suyash Laboratories Ltd. with the Company.
25 May 2012 Audited Results & Final Dividend -
09 Feb 2012 Others The Board has consider the Sucession Plan post retirement of Shri. Chandrakant V Gogri as the Chairman of the Company w.e.f August 16, 2012 on his attaining the age of 66 years.
01 Feb 2012 Quarterly Results & Interim Dividend -
11 Nov 2011 Quarterly Results -
29 Jul 2011 Quarterly Results -
25 May 2011 Audited Results & Final Dividend -
02 Feb 2011 Quarterly Results & Interim Dividend -
29 Oct 2010 Quarterly Results -
30 Jul 2010 Quarterly Results -
26 May 2010 Audited Results & Dividend -
25 Jan 2010 Quarterly Results -
20 Dec 2009 Allotment of Equity Shares The Board has allotted 4,00,000 Equity Shares of Rs. 10/- each fully paid up against exercise of option of Conversion by the holders of Conv. Warrants issued by the Company on preferential basis.
30 Oct 2009 Quarterly Results -
30 Jul 2009 Quarterly Results -
20 May 2009 Audited Results & Dividend -
29 Jan 2009 Quarterly Results (Revised)
20 Oct 2008 Quarterly Results -
06 Aug 2008 To call an EGM & Others To consider: Allotment of one Equity share of Rs 10/- each & to determine "Relevant Date" for the purpose said issue price for the Preferential Issue of the warrants.
28 Jul 2008 Quarterly Results -
13 May 2008 Audited Results & Final Dividend -
28 Jan 2008 Quarterly Results -
30 Oct 2007 Quarterly Results -
30 Jul 2007 Quarterly Results -
18 May 2007 Audited Results & Final Dividend Has not recommended any final dividend.
12 Mar 2007 Interim Dividend -
22 Jan 2007 Quarterly Results -
19 Oct 2006 Quarterly Results -
31 Jul 2006 Quarterly Results -
10 May 2006 Accounts & Dividend -
27 Jan 2006 Quarterly Results -
08 Nov 2005 Quarterly Results & Half Yearly Results -
29 Jul 2005 Quarterly Results & Accounts (Revised)
05 May 2005 Others Board has decided to acquire controlling stake in Suyash Laboratories Ltd (Suyash) thereby making it 51% subsidiary of the Company subject to necessary approvals from appropriate authority.
25 Apr 2005 Accounts, Qtr Results & F. Dividend -
08 Apr 2005 Allotment of Unsecured FCCB's Board has allotted 12750 Unsecured Foreign Currency Convertible Bonds (FCCBs) of US$ 1000 each aggregating to US$ 12,750,000 (US Dollar Twelve Million Seven Hundred Fifty Thousand Only).
21 Jan 2005 Quarterly Results -
31 Dec 2004 To issue securities like FCCB's Proposal to issue/offer securities like Foreign Currency Convertible Bonds (FCCB) and/or Equity Shares (through Depository Receipt Mechanism) and/or Fully Convertible Debentures.
29 Oct 2004 Quarterly Results -
28 Jul 2004 Accounts -